Ixekizumab is effective in the long-term management in moderate-to-severe plaque psoriasis: results from an Italian retrospective cohort study (the LOTIXE study)

Andrea Chiricozzia U.O.C. di Dermatologia, Dipartimento Scienze Mediche e Chirurgiche, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy;b Dermatologia, Dipartimento Universitario di Medicina e Chirurgia Traslazionale, Università Cattolica del Sacro Cuore, Rome, Italy

https://orcid.org/0000-0002-6739-0387 View further author information

Matteo Megnac Department of Clinical Medicine and Surgery, Section of Dermatology, University of Naples Federico II, Naples, ItalyView further author information

Alessandro Giuntad Department of Dermatology, University of Rome Tor Vergata, Rome, ItalyView further author information

Carlo Giovanni Carrerae Dermatology Unit, Department of Internal Medicine, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, ItalyView further author information

Paolo Dapavof Department of Biomedical Science and Human Oncology, Second Dermatologic Clinic, University of Turin, Turin, ItalyView further author information

Anna Balatog Unit of Dermatology, Department of Mentals and Physical Health and Preventive Medicine, Luigi Vanvitelli University of Campania, Naples, ItalyView further author information

Piergiorgio Malagolih Dermatology Unit, Azienda Ospedaliera San Donato Milanese, Milan, ItalyView further author information

Stella Mazzoccolii Department of Biomedical Science and Human Oncology, Section of Dermatology, University of Bari, Bari, ItalyView further author information

Aurora Parodij DiSSal Section of Dermatology, University of Genoa, University- Hospital San Martino IRCCS Genoa, Genoa, ItalyView further author information

Silvia Sabatinok Eli Lilly Italy S.p.A, Sesto Fiorentino, ItalyView further author information

Carlotta Buzzonik Eli Lilly Italy S.p.A, Sesto Fiorentino, ItalyCorrespondence[email protected]
View further author information

Chu-Han Huangl Opis Taiwan Inc, Taipei City, TaiwanView further author information

Alessandra Narcisim Dermatology Unit, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy;n Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, ItalyView further author information

show all

Ixekizumab is effective in the long-term management in moderate-to-severe plaque psoriasis: results from an Italian retrospective cohort study (the LOTIXE study)

Supplemental Material

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Ixekizumab is effective in the long-term management in moderate-to-severe plaque psoriasis: results from an Italian retrospective cohort study (the LOTIXE study)

Supplemental Material

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date